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Abstract
Mycotoxins, the toxic secondary metabolites of fungi, particularly produced by many 
species of Aspergillus, Fusarium and Penicillium, have affected animal and human health 
for over thousand years, whereas little has been discovered so far about these complex 
substances in poultry, which are generally very sensitive. Even though it varies by spe‐
cies and sex, some common effects are reduced feed intake, weight gain, feed efficiency, 
growth performance, immunity and hatchability along with increased mortality, organ 
damages (mainly kidney and liver), carcinogenicity, teratogenicity and decreased egg 
production. Besides their adverse health effects and the decrease in production rate, 
concerns over their importance in public health is still under debate. Decontamination 
approaches to reduce mycotoxins in feed are technologically diverse and based on 
chemical, biological and physical strategies. Chemical remediation strategies involve 
the conversion of mycotoxins via chemical reactions. Biological strategies involve vari‐
ous substances such as plant ingredients, enzymes and microorganisms. Physical pro‐
cesses include sorting, milling, dehulling, cleaning, heating, irradiation or combinational 
approaches. New strategies for the prevention and treatment of mycotoxicosis, including 
beneficial microorganisms/products, along with alternative treatments, including plant 
extracts/essential oils, are current hot topics in the poultry industry.
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1. Introduction
Mycotoxins, the secondary metabolites of fungi, are a global concern. At aerobic conditions, 
fungal growth in various feed raw materials is inevitable. There are about 200 species of 
fungi that produce mycotoxins. Majority of the fungi that form mycotoxin belong to three 
genuses: Aspergillus, Penicillium and Fusarium. Although more than 500 mycotoxins produced 
by these fungi are known, only some of these mycotoxins exert pathogenic characteristics. 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under th  terms of the Creative Commons
Attribution License (http://creativeco mons.org/licen es/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
The  poisoning in humans and animals caused by feeds and foods contaminated with myco‐
toxins may range from a slight reaction to death [1–6].
Fungal growth and mycotoxin production initiate in the cropland, during transportation 
or storage, and are affected by the environmental conditions including seasons, location of 
grain cultivation, drought and time of harvest. Long‐term analyses show that feed and feed‐
stuffs may be contaminated with mycotoxins, where these contaminated feed materials often 
include more than one mycotoxin [7]. Also, each of the cereals and oil seeds, available at the 
poultry feeds are vegetable substances obtained in different climatic conditions during veg‐
etation in the cropland, transport and storage. For this reason, although generally only one 
mycotoxin is produced in raw feed materials, multiple types of mycotoxins might be found in 
mixed feeds. Such co‐contamination examples in poultry feed are as follows: aflatoxin pres‐
ence with ochratoxins, T‐2 toxin or diacetoxyscirpenol; ochratoxins with T‐2 toxin or citrinin 
and vomitoxin with fumaric acid in the poultry feeds [8].
According to the Food and Agriculture Organization Report, 25% of the world's growing crops 
are affected by mycotoxins each year, with annual losses of around 1 billion metric tons of 
food and food products [9]. Generally, there is yield loss or reduced crop value due to diseases 
induced by toxigenic fungi, and losses in animal productivity and animal or human health costs 
are due to mycotoxin contamination. Apart from these, the extra costs include the management 
of mycotoxin, such as prevention, control, sampling, mitigation, labor loss and research costs. 
Thus, the economic problems related to mycotoxins concern all sections of society [10].
The reasons for mycotoxins to receive this particular attention are their undesirable health 
effects, decrease in the production rate due to the spoilage of feed, and overall economic effects 
which are reflected in international trade of food and food products. Therefore,  control of the 
fungal development and mycotoxin production are crucial for feed and animal  producers [6].
Mycotoxins are metabolized in the alimentary canal, liver or kidneys of the poultry in accordance 
with their chemical properties. Their transfer to poultry meat and eggs leads to undesirable 
health effects in humans, leading to major concerns in public health. Contamination of the feeds 
with fungi both damages their organoleptic properties and increases poisoning risk by decreas‐
ing their nutritional value. Toxicity of the mycotoxins depends on the amount of absorption, 
number of the metabolites that are formed, exposure period and sensitivity of the animal [1].
Some mycotoxins like aflatoxins (AF), ochratoxin A (OTA), fumonisins (FUM), deoxyniva‐
lenol (DON) and T‐2 toxin significantly affect the health and productivity of poultry species 
[11]. The aim of this review is to discuss in detail the important mycotoxins for poultry and 
their effects, along with the recent developments in prevention strategies.
2. Selected mycotoxins in poultry production
2.1. Aflatoxins
Aflatoxins, a group of harmful secondary metabolites characterized by polyketide‐
derived furanocoumarins, are produced mainly by Aspergillus fungi, such as A. flavus and 
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A.  parasiticus. Aflatoxins B1 (AFB1), G1 (AFG1) and their dihydroxy derivatives B2 (AFB2) 
and G2 (AFG2) naturally contaminate feeds. The presence of Aflatoxin M1 and M2 (AFM1 
and AFM2), the  4‐hydroxy metabolites of AFB1 and B2 in biological fluids including milk 
and tissues, is related to the exposure of the contaminated feed. International Agency for 
Research in Cancer (IARC) classified these highly toxic compounds as highly carcinogenic to 
humans (Group 1) [12].
AFB1 was explored in the early 1960s as the main etiological agent of “Turkey X Disease” 
responsible for the death of young turkeys in England as a result of contaminated peanut‐
based feed [13]. It is a widespread dietary hepatotoxin and hepatocarcinogen, and a major 
public health concern throughout the world. There are substantial species‐specific differences 
with regard to susceptibility to the toxic effects of AFB1, and domestic turkeys (Meleagris 
 gallopavo) are among the most susceptible species known so far [14, 15].
Aflatoxins are usually found in feed ingredients used for poultry rations. Most extensive 
forms of AF include B1, B2, G1 and G2, with AFB1 being the most widespread and bio‐
logically active form [16]. In fact, AFB1 is a “pro‐carcinogen” that is activated to a reactive 
form by the enzyme hepatic microsomal cytochrome P450 (CYP450), whereas electrophilic 
AFB1‐8,9‐epoxide (AFBO) is required for carcinogenic and toxic activity [13]. This compound 
forms AFB‐N7‐guanine adduct with DNA, which is not stable and is transformed into for‐
mamidopyrimidine. DNA adducts and repair activities through modulation are considered 
as important markers in carcinogenesis susceptibility. AFB‐N7‐guanine adduct in urine is also 
a potential biomarker of AFB1 exposure in animals and humans, and is vital for  estimating 
exposure conditions and potential risk in individuals consuming AFB1 [12].
Major AFB1 detoxification route is via conjugation of the AFBO to endogenous glutathione 
(GSH) catalyzed by the classical detoxification enzymes glutathione S‐transferases (GSTs) in 
mammals. Xenobiotics, including chemical carcinogens and environmental contaminants, 
are metabolized through detoxification processes in phase‐II metabolism through these pro‐
teins [17]. Due to the expression of A3 subunit (mGSTA3), mice bioactivate AFB1 and are 
assumed as AFB1‐resistant with great catalytic activity for AFBO. The present approach is 
that  efficiency of GST conjugation is a major “rate‐limiting” determinant for AFB1 action in 
individuals and species, irrespective of the efficiency of AFB1 bioactivation [14].
Aflatoxins cause a variety of effects in poultry, including decreased weight gain; poor feed 
efficiency; reduced egg production and egg weight; increased liver fat; changes in organ 
weights; reduction in serum protein levels; carcass bruising; poor pigmentation; liver damage; 
decreased activities of several enzymes involved in the digestion of starch, protein, lipids, and 
nucleic acids; and induction of immunosuppression. Evidence suggests that immunosuppres‐
sion caused by AF results in many disease outbreaks, vaccination failures and poor antibody 
titers [9, 11]. At necropsy, livers are usually pale and enlarged, as a result of aflatoxicosis. 
Histologically, liver lesions include congestion of the hepatic sinusoids, focal hemorrhages, 
centrilobular fatty cytoplasmic vacuolation and/or necrosis, biliary hyperplasia, and nodu‐
lar lymphoid infiltration. AF produces a malabsorption syndrome characterized by steator‐
rhea, hypocarotenoidemia, and decreased concentrations of bile salts and pancreatic lipase, 
 trypsin, amylase and RNase at levels that do not affect growth [11].
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Broiler chicken fed with 1.0 mg of AFB
1
/kg of diet were found to show decreased hepatic gene 
expression of superoxide dismutase, GST, and epoxide hydrolase and increased gene expres‐
sion of interleukin‐6 and CYP1A1 and 2H1 at cellular level [18].
Ingestion of 2 ppm AFB1 in male broiler chicks was found to alter various hepatic genes 
 causing up‐down regulation. For instance, enzymes having role in the production of energy 
and metabolism of fatty acids (carnitine palmitoyl transferase), development and growth 
(insulin‐like growth factor 1), coagulation (coagulation factors IX and X), protection of immune 
system (interleukins), antioxidant protection (GST), detoxification (epoxide  hydrolase) were 
found to be downregulated; while cell‐proliferation enzymes (ornithine decarboxylase) were 
upregulated [19].
A study reported that wild turkeys are significantly more resistant to AFB1 compared to 
domestic turkeys. Intensive breeding technologies and industrial alliance to produce modern 
domestic turkey led to the unintentional loss of AFB1‐protective GST alleles directing a rela‐
tive resistance. Actually, it has been shown that similar breeding pressures have eventuated 
in a remarkable loss of rare alleles and genetic diversity of single‐nucleotide polymorphisms 
in commercial breeds of chickens [14].
As mentioned previously, mycotoxins not only lead to the aforementioned economic and 
health problems in poultry, but also cause public health concerns due to their residues in food 
for human consumption. Major metabolites of AFB1 formed in chicken liver are AFM1 and 
AFB2a. AFB1 and B2 are then degraded to cyclopentanol and aflatoxicol through NADP. Both 
AFB1 and aflatoxicol are known to accumulate at the layer of the egg. While AFB1 and AFM1 
are present in chicken muscle and blood, the levels are found much higher in turkeys; the 
aflatoxicol levels were found to be less prominent in these animals. As a comparison, 1/1200 of 
AFB1 taken with feeds was found to accumulate in poultry meats, while 1/2200 of AFB1 was 
found to accumulate in the eggs [20].
2.2. Ochratoxins
Ochratoxins are a family of structurally related metabolites that are produced by Aspergillus 
and Penicillium species, including A. ochraceus, A. niger and P. verrucosum [21]. The most 
prevalent form is ochratoxin A (OTA) followed by its non‐chlorinated metabolite ochratoxin 
B (OTB) and the ethyl ester form ochratoxin C (OTC). OTA is the most frequent and relevant 
form of this family, while OTB and OTC are generally counted to be of lesser importance [22]. 
IARC classified ochratoxin A as a compound possibly carcinogenic to humans (Group 2B) [23].
Aspergillus species can generate OTA and OTB in parallel, and experiments with A. ochraceus 
have ascertained growth‐associated production of OTA and OTB, in which the yield and the 
ratio were dependent on the current culture terms. Mostly, the amount of OTB generated was 
quite lower than that of OTA, but under some situations, the level of OTB production was 
comparable to that of OTA. The informed generation ratios (OTA:OTB) ranged from 2:1 to 
34:1 [22]. Herein, it was reported that a complex interaction of various carbon sources, basal 
media and nitrogen sources seems to be considerable. High OTA production was related to an 
induction of OTA polyketide synthase expression, whereas OTB production is not connected 
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with transcription of the polyketide synthase gene. Laboratory fermentation experiments 
with A. ochraceus result in production of OTA at high yields (by 10 mg/g), OTB and temporar‐
ily also ochracin [24]. The intermediate metabolite OTβ was determined to be biotransformed 
in an effective manner into both OTA and OTB (14% and 19%, respectively), whereas OTα 
was biotransformed only into OTA (4.9%). In addition, OTB is inadequately converted (1.5%) 
into OTA, whereas some OTB may be produced by dechlorination of OTA [22].
OTA is hepatotoxic, nephrotoxic, neurotoxic, teratogenic and immunotoxic as confirmed by 
in vivo experiments with different animal species and various in vitro methods; its adverse 
effects include renal toxicity and carcinogenesis. Molecular studies with OTA revealed a non‐
DNA‐reactive genotoxic mechanism, which includes various epigenetic mechanisms prin‐
cipally connected to oxidative stress, compensatory cell proliferation and disruption of cell 
signaling and division [25]. However, a direct genotoxic mechanism including OTA bioactiva‐
tion and DNA adduct formation was also suggested [23] and this mechanism was found to 
be in accordance with some in vivo gene expression results [25]. Overall, the mode of action of 
OTA for renal carcinogenesis is yet under discussion.
Ochratoxins cause significant health problems and economic losses in poultry [26] and cause 
mycotoxic porcine nephropathy (MPN) [27]. Ochratoxin‐related diseases are characterized 
by severe kidney damage, which could be overtly related to the exposure to ochratoxins, 
sometimes in combination with different mycotoxins [27]. Likewise, a slow, progressive renal 
disease (endemic nephropathy, EN), characterized by cellular interstitial fibrosis, tubular 
atrophy, and karyomegaly predominately in proximal convoluted tubules was described in 
humans. The etiology of this disease is still unknown, but researchers agree that the causative 
agent is of natural origin. The most common causes of the multiethiologic disease, EN, were 
the aristolochic acid from the plant birthwort (Aristolochia clematitis) and mycotoxins (OTA 
and citrinin) [28].
OTA consists of an isocoumarin moiety linked through the 7‐carboxy group to the amino acid 
L‐β‐phenylalanine. OTA interferes with DNA, RNA and protein synthesis by inhibiting the 
enzyme phenylalanine‐tRNA synthetase at a cellular level. It also affects renal carbohydrate 
metabolism through the reduction of the renal mRNA coding for phosphoenolpyruvate car‐
boxykinase, a key enzyme in gluconeogenesis [11]. The effects of OTA on DNA, RNA and 
protein synthesis are thought to be due to the phenylalanine moiety of the toxin competing 
with phenylalanine in the enzyme‐catalyzed reaction. OTA also causes hypocarotenidemia 
which has more severe effects in broilers than AF [29].
Signs of OTA toxicity in poultry include weakness, anemia, decreased feed consumption, 
reduced growth rate and egg production, poor feathering and excessive mortality at high 
dietary concentrations [21]. Pathophysiological changes include decreased urine concentra‐
tion and glomerular filtration rate, impairment of proximal tubular function, and degenera‐
tion and ultrastructural alterations in renal integrity [30]. Increases in the relative weights of 
liver, spleen, pancreas, proventriculus, gizzard and testes have also been reported in poultry 
fed OTA [21]. A study found that the expression of Eimeria tenella and its pathological effects 
were maximum in the presence of OTA compared to the incidence of coccidiosis alone in 
broiler chicks [31].
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Comparative toxicity studies of OTA and OTB have shown that in vivo and in vitro effects are 
very different. OTB is overtly less toxic in vivo compared to OTA as indicated in different mod‐
els. LD50 values, found in a comparative study using 1‐day‐old chicks, were 120 μg for OTA 
(about 3.5 mg/kg) and 1890 μg for OTB (54 mg/kg) [32]. OTB is more easily excreted and has 
a lower affinity for plasma proteins, which may partly elucidate its lower toxicity. Both OTA 
and OTB toxins induce acute cytotoxic effects in vitro, ensuring similar amounts are taken up 
and are intracellularly bound, while other complex molecular mechanisms were introduced 
for chronic cytotoxicity studies. Moreover, it can be supposed that the small structural dif‐
ference, although not responsible for the toxicity, may be crucial for the differential uptake 
and binding in cells. Furthermore, OTC seems to be similarly acute toxic in vivo and in vitro 
compared to OTA; however, the mode of action of OTC and OTA remains to be explained. In 
a study, oral LD50 values were reported for OTC (216 mg animal‐1) and OTA (166 mg animal‐1) 
in day‐old chicks. Other ochratoxin ethyl or methyl esters showed lower toxicity compared 
to OTA. In comparison to OTA, the methyl ester of OTA was less toxic than OTA in day‐old 
chicks, while OTB methyl and ethyl esters were found to be non‐lethal to orally exposed day‐
old ducklings [22]. OTα is much less toxic (approximately 100 fold) than OTA as indicated in 
different studies [33]. It is obvious that the isocoumarin moiety alone is not effective but must 
be bound to phenylalanine to show toxic effects. With the current knowledge, no clear general 
toxicity ranking can be drawn; after all, OTA seems to be overall the most toxic, followed by 
OTC, OTB and OTα [33].
2.3. Fumonisins
Fumonisins (FUM) are a group of mycotoxins that were first isolated from cultures of 
Fusarium moniliforme and chemically characterized in 1988 by Gelderblom and colleagues [34]. 
Six different FUM have been identified (A1, A2, B1, B2, B3, B4) and their structures elucidated. 
However, fumonisin B1 (FB1) has been reported to be the predominant form produced by 
Fusarium moniliforme. Several other Fusarium species and a species of Alternaria have also 
been found to produce FB1 [35]. Based on all these animal studies, FB1 is classified by IARC 
as possibly carcinogenic to humans (Group 2B) [36].
The metabolism of fumonisin is yet to be elucidated. FB1 is metabolized into partially hydro‐
lyzed FB1 and then to the hydrolyzed form (HFB1) in both gastrointestinal tract and liver, 
where it persists at low concentration for few more days in pigs [37]. FB1 was found to be more 
toxic than HFB1 in piglets [38]. Even though N‐acylation of FB1 and the formation of HFB1 are 
shown in human cell lines and in rats, the metabolism in the avian species still remains uncer‐
tain and yet it is not possible to generalize the metabolic pathways in all animal species [39].
The mechanism that causes toxicity of fumonisins in animals seems to be due to the disrup‐
tion of sphingolipid metabolism. Present evidence shows that the FUM are specific inhibitors 
of ceramide synthase (sphinganine/sphingosine N‐acyltransferase), a key enzyme needed for 
the synthesis of ceramide and more complex sphingolipids. Inhibition of this enzyme system 
causes an increase in tissue concentrations of the sphingolipids sphingosine (SO) and sphin‐
ganine (SA), and a change in the SA:SO ratio. An increase in the SA:SO ratio has been demon‐
strated in tissues of broilers, turkeys, and ducklings fed FB1 [40].
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In comparison to horses and swine, two susceptible species, chicks and turkeys, are relatively 
resistant to the toxic effects of FB1. Mild to moderate toxicity was reported in chicks, ducks and 
turkeys fed rations containing 75–400 mg FB1/kg for 21 days. The primary changes in chicks, 
ducks and turkeys were decreased body weight gain and liver pathology [41–43]. Hepatic 
changes in chicks were multifocal hepatic necrosis and biliary hyperplasia. Hepatocellular 
hyperplasia and increased extramedullary hematopoiesis were also noted in one study 
[44]. The primary liver pathology observed in turkeys fed with 150–300 mg FB1/kg [43] and 
ducklings fed with 400 mg FB1/kg [41] were diffuse hepatocellular hyperplasia, with biliary 
hyperplasia (more evident in turkeys). In studies designed to evaluate the chronic effects of 
FB1, chick performance up to 7 weeks was not affected by up to 50 mg FB1/kg diet, whereas 
turkeys fed with 50 mg FB1/kg diet had lower feed intakes than birds fed 0 or 25 mg FB1/kg 
diet [45].
2.4. Trichothecenes
Trichothecene mycotoxins are a group of fungal metabolites with the same basic backbone 
structure and include T‐2 toxin, HT‐2 toxin, diacetoxyscirpenol (DAS), monoacetoxyscirpenol 
(MAS), neosolaniol, 8‐acetoxyneosolaniol, 4‐deacetylneosolaniol, nivalenol, 4‐acetoxynivale‐
nol (Fusarenone‐X), DON (vomitoxin) and 3‐acetyldeoxynivalenol. They are known as the 
most potent small molecule inhibitors of protein synthesis and the main toxic effect at the cel‐
lular level appears to be the primary inhibition of protein synthesis followed by a secondary 
disruption of DNA and RNA synthesis [11]. The overall conclusion by IARC was that toxins 
derived from Fusarium sporotrichioides are not classifiable as to their carcinogenicity to humans 
(Group 3) [46].
For livestock, the most important trichothecene mycotoxin is DON, which is commonly a con‐
taminant of corn, wheat and other commodity grains. Lesser amounts of T‐2 toxin and DAS 
are found sporadically in the same sources. Poultry and cattle are more tolerant of tricho‐
thecenes than are pigs. Compared to the related DON, T‐2 toxin is less frequent in crops. 
Some reports indicate that trichothecenes such as DON, nivalenol and fusarenon X are more 
frequent (57%, 16% and 10% of tested grain samples) in European grain samples than other 
trichothecenes like T‐2 toxin (20%), HT‐2 toxin (14%), T‐2 tetraol (6%), neosolaniol (1%), DAS 
(4%), MAS (1%) [47].
Trichothecene poisoning in poultry is acute or chronic. Acute poisoning has a characteristic 
clinical picture and can be readily diagnosed, while chronic poisoning shows unspecific clini‐
cal symptoms [48].
Toxic effects of trichothecenes include oral lesions, growth retardation, abnormal feathering, 
decreased egg production and egg shell quality, regression of the bursa of Fabricius, peroxida‐
tive changes in liver, abnormal blood coagulation, leucopoenia and proteinemia, and immu‐
nosuppression [49]. Concentrations of T‐2 that cause oral lesions are lower (0.4 mg/kg) than 
concentrations reported to decrease chick performance (3–4 mg/kg) [11]. In a comprehensive 
review, Danicke [49] concluded that broiler performance is affected at dietary concentrations 
of 3–4 mg/kg of T‐2 toxin, whereas ducks were affected when the dietary  concentration was 
as low as 0.4 mg/kg.
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T2 toxin was found to decrease the immune response, represented by the decrease of lym‐
phoid cells in the bone marrow, thymus and spleen causing resistance to infectious diseases 
including salmonellosis and Escherichia coli and cause resistance to treatments of these diseases 
in poultry [50]. In broilers, T‐2 toxin may cause a decrease in body weight and relative weights 
of bursa of Fabricius, thymus, and spleen, enlarged liver, friable, and yellowish discoloration 
with distended gall bladder during Mycoplasma gallisepticum infections. Microscopical find‐
ings include vacuolar degeneration along with augmented hyperplasia in bile duct epithelia; 
Kupffer cell activity and infiltration of inflammatory cells in liver; vacuolar degeneration with 
pyknotic nuclei in kidney; lymphocytolysis and reduction of prominent reticuloepithelial 
cells in lymphoid organs; desquamation of villous‐type epithelial cells and lymphoid intru‐
sion in the submucosa of proventriculus; mild hemorrhage along with inflammatory cells in 
the heart; desquamation and erosion of the mucosa in trachea and the thickening of the air 
sacs along with edema and the presence of inflammatory cells in air sacs [51]. The toxic effect 
also manifests as reduced proliferation of lymphocytes stimulated by phytohemagglutinin 
and lipopolysaccharide in Pekin duck broilers [52].
DON was found to be less toxic than T‐2 toxin, and the level of DON that affects chick per‐
formance is still disputed. Some researchers [53, 54] reported toxic effects at 16 mg/kg diet, 
whereas others [55] report no toxic effect until dietary concentrations exceeded 116 mg/kg of 
DON. A review paper summarizing results of 49 studies with DON concluded that a dietary 
concentration of 5 mg/kg had no negative effects on performance [56]. DON has also been 
demonstrated to have both immunosuppressive and immunomodulating effects in poultry 
[49]. Recent studies indicate that DON at concentrations ranging from 1 to 7 mg/kg diet sig‐
nificantly alters several key functions of the intestinal tract including decaying villus surface 
area available for absorption and altering the permeability of the alimentary canal [57].
3. Interactions among mycotoxins
In nature, co‐occurrence of mycotoxins is generally observed. Meanwhile, for many years the 
research community focused on the occurrence of singular mycotoxins. Nowadays, scientific 
interest is shifted to studies involving multiple mycotoxins using various co‐occurrence sce‐
narios. One fungus may produce many different mycotoxins, and the same mycotoxin may 
be produced by several species. A paper conducted a meta‐analysis of publications (> 100) 
describing toxicological interactions among mycotoxins. Results indicated that most of the 
studies showed a synergistic or additive interaction on animal performance. However, results 
with respect to other response variables indicated that there were many types of interactions 
ranging from synergistic to antagonistic for the same association [58]. They also observed 
from their review that a combination of mycotoxins, at concentrations that individually 
should not cause negative effects, may negatively affect animals.
The individual and combined effects of dietary AFB1 and FB1 on liver pathology, serum levels 
of aspartate amino‐transferase (AST) and plasma total protein (TP) of broilers were quantified 
from 8 to 41 days of age with the dietary treatments of AFB1 (0, 50 and 200 μg AFB1/kg), and 
FB1 (0, 50 and 200 mg FB1/kg). Following treatment, AST levels were found to be higher in 
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all treatment groups (except 50 mg FB1) compared to controls at day 33. TP levels were found 
to be reduced at 6 days post feeding in AFB1‐treated group (200 μg) and in FB1 combination 
group. At 33 days post feeding, the combination group (200 μg AFB1 and 200 mg FB1) were 
found to have higher plasma TP, proliferation of bile duct and trabecular disorders in liver 
tissue compared to control; while the changes in other groups were insignificant compared to 
controls. Overall AFB1 alone and in combination caused damage in liver at varying degrees 
and an increase of serum AST levels [59].
Aflatoxicosis causes a reduction in the production of egg and a decrease in egg weight in lay‐
ing hens. Meanwhile, the antagonistic effects of AF and FB on egg production were reported 
in quails, where the decrease in egg production in FB‐only treated group was much evident 
compared to AF+FB combination [60].
Few studies examined the combined effect of AF and FB on immunity. AF and FB co‐contam‐
inated feed was found to reduce lymphocyte proliferation by mitogenic stimulation as less 
than additive [61] or as additive [62] compared to single contamination. A study indicated 
a synergistic decrease of the antibody titers against Newcastle disease [59]. On the contrary, 
another study demonstrated an unexpected increase and an additive effect of the two toxins 
when looking at the hemagglutination titers against sheep red blood cells in turkey poults. 
However, the phytohemagglutinin delayed hypersensitivity response was not affected by 
dietary treatment. These results indicate that FB1 and AF, alone and in combination, can 
adversely affect poult performance and health [63].
As is known, both AF and OTA reduce egg production and hatchability. The combined effects 
of these two toxins were studied in laying hens [64, 65]. An additive interaction of AF and 
OTA was observed on egg production and on the feed efficiency (consumption for egg pro‐
duction) [64]; meanwhile this interaction was dependent on the concentration, resulting from 
synergistic to slightly lower than additive effect and also modulates the protein and energy 
usage [65].
AF‐ and OTA‐contaminated feed resulted in microscopic lesions in the liver and kidneys, 
along with respective target organs in chicken, while contradictory results are presented 
in different studies. As such, OTA in the diet was found to prevent the hepatic fatty infil‐
tration caused by AF in chicken [66]. Pigs fed the co‐contaminated diet offer the same 
hepatic lesions as those fed with the diet contaminated with AF alone [67]. On the con‐
trary, a study recorded more severe hepatic lesions in chickens taking the co‐contaminated 
diet, with granular and vacuolar degenerative changes, necrosis of liver parenchyma and 
areas of hemorrhages [68]. The same conflict was realized for the histology of the kidney. 
In pigs, less severe renal lesions and lower creatinine and blood urea nitrogen concentra‐
tions were observed in animals fed the co‐contaminated diet compared to animals fed the 
OTA‐contaminated diet [67]. In contrast, a study observed that renal injuries appeared ear‐
lier and were more developed in chickens fed a multi‐contaminated diet than in animals 
taking the mono‐contaminated diets, which caused destruction of tubular epithelium, with 
detachment of tubular cells from basement membrane [68]. The species used may explain 
these conflicts. Apart from that, chronic DON exposure did not induce any effect on FB1 
 toxicokinetics in broilers [69].
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The results on combination toxicity are yet quite limited and occasionally conflicting. 
Nowadays, very little is known about mycotoxin interactions although combined exposure 
is clearly more relevant to real‐life conditions. It is known that the combined effects of myco‐
toxins are mostly additive or synergistic; whereas depending on the concentrations and the 
in vitro model employed, antagonistic interactions have also been determined. The results on 
multiple mixtures are still inadequate [22].
4. Prevention and control
Prevention of fungi production in the feeds may be achieved by always keeping the feeds 
fresh, keeping the humidity low and equipment clean and also adding fungistatic substances. 
Humidity exceeding 11% promotes fungal production in cereals and feed. Storage conditions 
that afford high relative humidity also significantly affect humidity content of the feed. Good 
ventilation of the storehouse removes humidity from the raw material of the feed and store‐
house. Physically damaged cereals are more prone to fungus production compared to the 
healthy ones. Changing the raw materials at the places where they are stored at short intervals 
decreases mycotoxin formation [2, 3, 6].
Research efforts progressively increase to develop mitigation strategies based on risk monitoring, 
risk characterization, prevention, intervention, and remediation strategies for multiple mycotox‐
ins, initiating from critical points along the production chain comprising field, storage, process‐
ing and transportation. However, monitoring and good agricultural, storage, and transportation 
practices along with an effective Hazard Analysis and Critical Control Point (HACCP) approach 
do not completely prevent mycotoxin presence in the food or feed chain. Decontamination strat‐
egies then offer a last resort to salvage contaminated batches along the production chain [70].
Considering the variation of mycotoxin structures, it could be inferred that there is no single 
method which can be used to deactivate mycotoxins in feed. Therefore, different strategies 
have to be combined in order to specifically target individual mycotoxins without affecting 
the quality of feed [11].
Decontamination strategies to reduce mycotoxins in food and feed commodities are techno‐
logically diverse and based on chemical, biological and physical approaches. Chemical reme‐
diation strategies involve the conversion of mycotoxins via chemical reactions. Ammoniation, 
alkaline hydrolysis, peroxidation, ozonation and the use of bisulphites are reported to be 
effective on one or more mycotoxins but a detailed insight into the toxicity of eventual end 
products or the impact on palatability and nutritive quality is questionable [71].
Biological approach in treatment strategies involves various substances (algae, plant ingre‐
dients, etc.) that protect critical organs such as the liver and strengthen the immune system 
of animals. Enzymatic or microbial detoxification, also referred to as “biotransformation” or 
“biodetoxification”, uses microorganisms or purified enzymes thereof to catabolize the entire 
mycotoxin or transform or cleave it to less or non‐toxic compounds [11]. Some microorgan‐
ism such as Rhodococcus erythropolis [72], Armillariella tabescens [73] and Myxococcus fulvus 
[16] have been suggested to have different AF‐degrading ability. Rhizopus oryzae [74], Bacillus 
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 licheniformis [75] and Pseudomonas sp [76] were searched for their abilities to degrade ZEA. 
Some studies found that B. subtilis had protective effects against aflatoxicosis in layers and 
broilers fed naturally AF‐contaminated diets and also healed ZEA toxicosis in pre‐pubertal 
gilts when fed diets including ZEA. Therefore, B. subtilis, as a new feed additive for biodeg‐
radation of AF and ZEA may have promising potential in feed industrial applications [77].
Some physical processes aim to remove highly contaminated fractions from bulk material 
through sorting, milling, dehulling, cleaning, heating, irradiation or combinational approaches 
[78, 79]. Another physical removal strategy is the use of inorganic or organic mycotoxin bind‐
ers [80]. Due to low feed inclusion requirements and easy management of AF enterosor‐
bents, the widespread acceptance of these products by the farm animal industry has led to 
the introduction of a variety of diverse materials and/or complex mixtures for AF binding. 
These have been labeled as mycotoxin enterosorbents, binders, sequestrants, interceptor mol‐
ecules, trapping agents, adsorbents, toxin sorbents, and so on. These materials (and/or mix‐
tures) are reported to contain smectite clays, zeolites, kaolinite, mica, silica,  charcoal, sodium 
bentonite and various biological constituents including chlorophyllins, yeast  products, lactic 
acid bacteria, plant extracts and algae. Some contain smectite or zeolite minerals that have 
been amended with natural or synthetic surfactants resulting in hydrophobic organoclays or 
organozeolites [81–84]. There is considerable evidence indicating that smectite clays are the 
most effective AF enterosorbents. Although these adsorbing binders have some promising 
features, some may have adverse nutritional effects due to binding of vitamins and minerals 
or reducing the efficacy pharmacokinetics of antibiotics [85]. Also, possible dioxin contamina‐
tion might pose a risk for using natural clays in case of forest and trash fire near the sources 
[86]. Furthermore, the adsorption efficacy of binding agents is limited to only a few myco‐
toxins, such as AF, ergot alkaloids, and some other fungal toxins, while binders have been 
shown to be ineffective for trichothecenes [87]. Therefore, alternative approaches for efficient 
detoxification of mycotoxins are required.
Use of microorganisms and their specific products such as enzymes to detoxify specific myco‐
toxins not only work for non‐adsorbable mycotoxins, but for all other toxins for which respec‐
tive microbes can be isolated from nature. This approach has been known for a long time, even 
longer than the binder concept. Within few years after the discovery of AF, the first report on 
a bacterium capable of detoxifying AF by catabolization was published [88]. Since then, many 
microorganisms were isolated from different habitats such as the gastrointestinal tract (GIT) 
of animals, soil, mycotoxin‐contaminated materials (e.g., grains) and insects feeding on such 
materials. The ability of various bacteria, yeast, fungi and enzymes in detoxifying mycotox‐
ins by transformation, cleavage and catabolization has been recently reviewed [89]. However, 
only a few of these organisms were useful or further investigated for practical applications in 
animal nutrition. Such microorganisms or enzymes need to fulfill many different requirements 
before they can be used for gastrointestinal detoxification of mycotoxin in animals, such as:
 ‐ The microorganism and its reaction products need to be non‐toxic and safe.
 ‐ High detoxification reactivity.
 ‐ Good technological properties (fermentation, downstream processing, stabilization).
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 ‐ High stability in feed and during feed processing.
 ‐ No negative impact on feed (ingredients).
 ‐ Compatibility and stability in the GIT.
 ‐ Detoxification reaction in the GIT needs to be fast and as complete as possible.
One of the microorganisms which has been further developed for practical application 
is Trichosporon mycotoxinivorans, a yeast strain capable of detoxifying OTA and ZEN [90]. 
Application of this yeast in poultry diets has been proven to detoxify OTA. Another organism 
is an anaerobic rumen bacterium BBSH 797 (Genus Novus of family Coriobacteriacae, formerly 
Eubacterium) which was isolated and developed as a trichothecene‐detoxifying feed additive 
[91]. BBSH 797 detoxifies trichothecenes by cleavage of the 12, 13 epoxide ring resulting in deep‐
oxy trichothecenes. Several microorganisms, mainly aerobic bacteria and also yeasts, with FUM 
degradation properties were also explored and isolated in order to detoxify FUM. However, for 
various reasons, none of these microorganisms were found to be useful as a mycotoxin‐deac‐
tivating feed additive. Therefore, the catabolic pathway of FUM degradation was investigated 
and the gene coding for the key enzyme of FUM detoxification (FUMzyme) was identified, 
cloned and expressed in a yeast strain [92]. FUMzyme  (carboxyl‐esterase) was further devel‐
oped and tested in swine for gastrointestinal detoxification of FUM by cleaving the tricarbal‐
lylic side chains of FUM leading to the non‐toxic metabolite hydrolyzed FUM (HFB1) [93].
One of the common approaches to overcome mycotoxicosis in poultry is using herbal prod‐
ucts including essential oils as plant‐based fumigants in feed storage [94]. Essential oils are 
complex compounds, and their chemical composition and concentrations of various com‐
pounds are variable. Essential oils basically consist of two classes of compounds, the terpenes 
and phenylpropenes, depending on the number of 5‐carbon building blocks. For example, 500 
ppm of the ethanolic extract of Thymus vulgaris could partially restore the negative impact of 
AFB1 (600 ppb) in commercial broilers [9]. They suggested that this herb can be used as natu‐
ral non‐antibiotic feed additive on broilers in the prevention of aflatoxicosis. As a result of the 
change in diet (change in nutrients, phytochemicals, contamination, xenobiotics), the levels of 
the drug‐metabolizing enzymes (phase‐I and phase‐II) are expected to change, which would 
eventually lead to a change in AFB1 adducts. On the other hand, as phenolic phytochemicals 
have antioxidant effects at varying degrees due to their various chemical structures, they are 
assumed to have a protective role in the cellular components against free radical–induced 
damage caused by aflatoxicosis [95]. Apart from that, a herbal mycotoxin binder comprising 
of a combination of minerals (extra purified clay containing diatomaceous earth minerals), 
antioxidants (curcuminoids extracted from turmeric) and enzymes (Epoxidases and Esterases) 
in proportions of 15, 10 and 75%, respectively, partially restored feed consumption and egg 
production, alleviating some side effects of AFB1 (500 ppb in feed) in broiler breeders [96].
5. Conclusion
Understanding the occurrence and prevalence of mycotoxins and their individual as well as 
additive negative effects on poultry has become imperative. New insights on actual  microbial 
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detoxification routes are needed in the field, which could be based on the biodegradation metab‐
olisms of non‐mycotoxins found in diverse microbial communities. Indeed, many hazardous, 
undesirable, deleterious or recalcitrant molecules in other research fields share structural analo‐
gies with diverse mycotoxins and are reported to be successfully degraded by microorganisms. 
These unexplored worlds may serve as resource for cutting‐edge research in the field of myco‐
toxin remediation or in the field of metagenomics screening surveys in search for new microbial 
degraders of mycotoxins. The usage of latest analytical techniques such as liquid chromatogra‐
phy tandem‐mass spectrometry will increase the precision in determination of the concentra‐
tions of multiple mycotoxins present in agricultural commodities, at once. Latest enzymatic 
deactivation technologies help to eliminate the mycotoxins that cannot be bound using binder 
products. Overall, mycotoxins still impose a great risk for the  poultry sector and alternative 
approaches for the prevention are still being sought by researches around the world.
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